The team behind the platform.
Scientists, engineers, and operators building the next generation of spatial epigenomics tools — from chip fabrication to bioinformatics to customer delivery.
Kenneth Wang
Experienced investor and entrepreneur.
Colin Ng, MS
VP at IsoPlexis, Blavatnik Fellow at Yale University.
Jeffrey Sabina
Extensive R&D leadership experience from IsoPlexis, Detect, QuantumSi, and Thermo.
Jennifer Garbarino, PhD
Yale PhD with a focus on epigenetic mechanisms.
Katelyn Noronha, PhD
Yale PhD with a focus on cancer epigenetics.
Jiaying Chen, PhD
Yale PhD with a focus on transcriptional and epigenetic regulation.
Jose Perez
Experienced microfluidic chips and hardware engineer.
Guidance from the field's leading scientists.
Researchers and clinicians shaping the direction of the technology and the questions it can answer — across cancer, computation, and systems biology.
Rong Fan, PhD
Professor of BME at Yale University.
Jennifer Chayes, PhD
Dean, College of Computing, Data Science, and Society, UC Berkeley.
James Heath, PhD
President and Professor, Institute for Systems Biology.
Jerry S.H. Lee, PhD
Chief Scientific Officer, Lawrence J. Ellison Institute.
Arnold Levine, PhD
Professor Emeritus, Princeton University.
Strategic stewardship.
The board guiding AtlasXomics's long-term direction — bringing capital markets, life sciences, and operating experience to the table.
Kenneth Wang
Experienced investor and entrepreneur.
Gregory P. Ho
President and Head of Opportunity Zones at SMC.
John L. (Launny) Steffens
Founder and Senior Managing Director of Spring Mountain Capital; former Vice Chairman of Merrill Lynch.